GWAYF (Greenway Greenhouse Cannabis) Days Payable: 85.17 (As of Dec. 2025) — 46% Below Median


GWAYF Greenway Greenhouse Cannabis Corp GWAYF
24 GF Score
Price $0.10
GF Value $0.28
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Greenway Greenhouse Cannabis Days Payable?

Greenway Greenhouse Cannabis GWAYF +0.53% 24 Days Payable is 85.17 as of Dec. 2025, which is 46% below its 10-year median of 156.82. GuruFocus rates GWAYF with a GF Score™ of 24/100 and a GF Value™ of $0.28 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 920 Drug Manufacturers companies, Greenway Greenhouse Cannabis ranks better than 54.89% on this metric.

Greenway Greenhouse Cannabis's average Accounts Payable for the three months ended in Dec. 2025 was $1.13 Mil. Greenway Greenhouse Cannabis's Cost of Goods Sold for the three months ended in Dec. 2025 was $1.21 Mil. Hence, Greenway Greenhouse Cannabis's Days Payable for the three months ended in Dec. 2025 was 85.17.

The historical rank and industry rank for Greenway Greenhouse Cannabis's Days Payable or its related term are showing as below:

GWAYF' s Days Payable Range Over the Past 10 Years
Min: 74.64   Med: 156.82   Max: 253.7
Current: 99.72

During the past 5 years, Greenway Greenhouse Cannabis's highest Days Payable was 253.70. The lowest was 74.64. And the median was 156.82.

GWAYF's Days Payable is ranked better than
54.89% of 920 companies
in the Drug Manufacturers industry
Industry Median: 90.835 vs GWAYF: 99.72

Greenway Greenhouse Cannabis's Days Payable declined from Dec. 2024 (98.22) to Dec. 2025 (85.17). It may suggest that Greenway Greenhouse Cannabis accelerated paying its suppliers.


Greenway Greenhouse Cannabis Days Payable Historical Data

* Premium members only.

The historical data trend for Greenway Greenhouse Cannabis's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenway Greenhouse Cannabis Days Payable Chart

Greenway Greenhouse Cannabis Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Days Payable
0.00 0.00 253.67 155.64 76.76

Greenway Greenhouse Cannabis Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 98.22 72.76 174.15 114.34 85.17

GWAYF vs ZTS, UTHR: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Greenway Greenhouse Cannabis's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Greenway Greenhouse Cannabis Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Greenway Greenhouse Cannabis's Days Payable distribution charts can be found below:

* The bar in red indicates where Greenway Greenhouse Cannabis's Days Payable falls into.


GWAYF
24GF Score
Greenway Greenhouse Cannabis Corp GWAYF
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenway Greenhouse Cannabis Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Greenway Greenhouse Cannabis's Days Payable for the fiscal year that ended in Mar. 2025 is calculated as

Days Payable (A: Mar. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Mar. 2024 ) + Accounts Payable (A: Mar. 2025 )) / count ) / Cost of Goods Sold (A: Mar. 2025 )*Days in Period
=( (1.027 + 1.103) / 2 ) / 5.064*365
=1.065 / 5.064*365
=76.76

Greenway Greenhouse Cannabis's Days Payable for the quarter that ended in Dec. 2025 is calculated as:

Days Payable (Q: Dec. 2025 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Sep. 2025 ) + Accounts Payable (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (1.144 + 1.113) / 2 ) / 1.209*365 / 4
=1.1285 / 1.209*365 / 4
=85.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 85.17 mean?
Greenway Greenhouse Cannabis (GWAYF) has a Days Payable of 85.17 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Greenway Greenhouse Cannabis and its competitors. This is 46% below median its historical median of 156.82. Over the past decade, Greenway Greenhouse Cannabis' Days Payable has ranged from 74.64 to 253.70. According to the industry distribution chart, Greenway Greenhouse Cannabis ranks #415 out of 920 companies in the Drug Manufacturers industry, placing it in the top 45.1%.
Is Greenway Greenhouse Cannabis' Days Payable too high?
Greenway Greenhouse Cannabis' current Days Payable of 85.17 is 46% below median its 10-year median of 156.82. Over the past 10 years, this metric has ranged from a low of 74.64 to a high of 253.70. The Drug Manufacturers industry median Days Payable is 90.84. Greenway Greenhouse Cannabis' value of 85.17 is 6.2% below this industry median. Based on the distribution chart, Greenway Greenhouse Cannabis ranks #415 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Greenway Greenhouse Cannabis has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Greenway Greenhouse Cannabis' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Greenway Greenhouse Cannabis ranks #415 out of 920 companies for Days Payable. This puts Greenway Greenhouse Cannabis in the upper half of its industry. The industry median Days Payable is 90.84. Greenway Greenhouse Cannabis' value of 85.17 is 6.2% below this benchmark. Historically, Greenway Greenhouse Cannabis' own Days Payable has ranged from 74.64 to 253.70 over the past decade. While the company's 10-year median is 156.82 vs. the industry median of 90.84, Greenway Greenhouse Cannabis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Greenway Greenhouse Cannabis's current Days Payable of 85.17 is 6.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Greenway Greenhouse Cannabis and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Greenway Greenhouse Cannabis's current Days Payable is 85.17, which is 46% below median its own 10-year median of 156.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenway Greenhouse Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Greenway Greenhouse Cannabis (GWAYF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.28, compared to a current price of $0.10 — trading 63.9% below its estimated fair value. The current Days Payable is 85.17, which is 46% below median its 10-year median of 156.82 and 6.2% below the Drug Manufacturers industry median of 90.84. Greenway Greenhouse Cannabis' overall GF Score™ is 24/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Greenway Greenhouse Cannabis (GWAYF), the current Days Payable is 85.17 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Greenway Greenhouse Cannabis (GWAYF) Overvalued in 2026?

Based on GuruFocus' analysis, Greenway Greenhouse Cannabis stock appears to be undervalued. The current stock price of $0.10 is trading 63.9% below its estimated GF Value™ of $0.28. GuruFocus considers Greenway Greenhouse Cannabis to be Possible Value Trap.

Key valuation signals for GWAYF:

  • Days Payable: 85.17 (46% below median its 10-year median of 156.82)
  • GF Value™: $0.28 vs. price of $0.10 (63.9% below fair value)
  • GF Score™: 24/100 with 5 warning signs
  • Industry Position: 6.2% below the Drug Manufacturers median (#415 of 920)

No single metric tells the full story. See the GWAYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Greenway Greenhouse Cannabis Business Description

Other Exchanges GWAY:Canada
Address 1478 Seacliff Drive, Kingsville, ON, CAN, N9Y 2M2
Greenway Greenhouse Cannabis Corp is licensed to cultivate, process and sell to ensures harvests always consist of the highest quality cannabis strains with resinous flowers, trichomes, and rich cannabinoid profiles. The Company's nursery facility is located in Kingsville, Ontario, and its flowering and processing facility is located in Leamington, Ontario. The business model is to supply bulk packaged, high quality cannabis to the Canadian, cannabis industry at prices that ultimately provide a value proposition to the consumers. Greenway has three divisions with various locations; Greenway Nursery, Greenway Cultivation and future plans for Greenway Farmgate Retail Store.
24GF Score

Get the complete analysis for GWAYF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price
$0.28
GF Value